XML 67 R46.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Financial Information of the Parent Company (Tables)
12 Months Ended
Dec. 31, 2015
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY [Abstract]  
Schedule of balance sheets

As of December 31,

2014

2015

RMB RMB

US$ (Note 2(d))

 

ASSETS

   

Current assets

             

Cash and cash equivalents

 

1,323,280

 

1,090,097

 

168,282

 

Amounts due from subsidiaries

 

18,000

 

3,468,022

 

535,370

 

Prepayments and other current assets

 

1,561

 

4,888

 

755

 

Total current assets

 

1,342,841

 

4,563,007

 

704,407

 

 

 

 

 

 

 

 

 

Intangible assets

 

 

607,669

 

93,808

 

Total assets

 

1,342,841

 

5,170,676

 

798,215

 
               

LIABILITIES AND EQUITY

             

Current liabilities

             

Accrued expenses and other current liabilities

 

16,723

 

664,420

 

102,568

 

Total current liabilities

 

16,723

 

664,420

 

102,568

 

Non-current liabilities

             

Investments (income)/ deficit in subsidiaries and VIE

 

(82,605

)

1,185,106


182,949


Total non-current liabilities

 

(82,605

)

1,185,106


182,949


Total liabilities

 

(65,882

)

1,849,526


285,517


               

Equity

             
Ordinary shares (US$0.0001 par value; 1,000,000,000 shares (including 780,000,000 Class A shares, 120,000,000 Class B shares and 100,000,000 shares to be designated by the Board of Directors) authorized as of December 31, 2014 and 2015; 188,435,922 shares (including 82,487,876 Class A shares and 105,948,046 Class B shares) and 286,970,892 shares (including 269,597,392 Class A shares and 17,373,500 Class B shares) issued and outstanding as of December 31, 2014 and 2015, respectively)
 

121

 

181

 

28

 

Additional paid-in capital

 

2,298,727

 

5,482,367

 

846,332

 

Accumulated other comprehensive income/(loss)

 

(21,081

)

167,025


25,784


Accumulated deficit

 

(869,044

)

(2,328,423

)

(359,446

)

Total Tuniu Corporation shareholders' equity

 

1,408,723

 

3,321,150

 

512,698

 

Total liabilities and equity

 

1,342,841

 

5,170,676

 

798,215

 
Schedule of statements of comprehensive loss

For the Years Ended December 31,

2013

2014

 

2015

 
       

US$ (Note 2(d))

 

Operating expenses

                 

Research and product development

 

 

 

 

 

Sales and marketing

 

 

 



General and administrative

 

(4,027

)

(5,617

)

(19,016

)

(2,936

)

Share of loss of subsidiaries and affiliated entities

 

(77,414

)

(446,159

)

(1,341,212

)

(207,047

)

Other operating income

 

 

415

 

 

 

Total operating expenses

 

(81,441

)

(451,361

)

(1,360,228

)

(209,983

)

Loss from operations

 

(81,441

)

(451,361

)

(1,360,228

)

(209,983

)

Other income/(expenses)

                 

Interest income

 

1,738

 

6,619

 

19,183

 

2,961

 

Foreign exchange gains/(losses),net

 

71

 

(3,116

)

(119,161

)

(18,395

)

Other income, net

 


 

 

827

 

128

 

Loss before income tax expense

 

(79,632

)

(447,858

)

(1,459,379

)

(225,289

)

 

 

 

 

 

 

 

 

 

 

Net loss

 

(79,632

)

(447,858

)

(1,459,379

)

(225,289

)

Deemed dividends to preferred shareholders

 

(59,428

)

(15,606

)



Net loss attributable to ordinary shareholders

 

(139,060

)

(463,464

)

(1,459,379

)

(225,289

)

                   

Net loss

 

(79,632

)

(447,858

)

(1,459,379

)

(225,289

)

Other comprehensive income/(loss)

                 

Foreign currency translation adjustment, net of nil tax

 

(5,331

)

(1,358

)

188,106


29,038


Comprehensive loss

 

(84,963

)

(449,216

)

(1,271,273

)

(196,251

)

Schedule of statements of cash flows

For the Years Ended December 31,

2013

2014

 

2015

 
RMB RMB   RMB  

US$ (Note 2(d))

 

Cash (used in) provided by operating activities

(3,058

)

2,636

 

645,364

 

99,627

 

Cash used in investing activities

 

(93,595

)

(518,690

)

(3,434,719

)

(530,229

)

Cash provided by financing activities

 

306,360

 

1,540,397

 

2,442,860

 

377,113

 
                   

Effect of exchange rate changes on cash and cash equivalents

 

(5,250

)

(3,040

)

113,312


17,492


Net increase /(decrease) in cash and cash equivalents

 

204,457

 

1,021,303

 

(233,183

(35,997

Cash and cash equivalents at the beginning of year

 

97,520

 

301,977

 

1,323,280

 

204,279

 

Cash and cash equivalents at the end of year

 

301,977

 

1,323,280

 

1,090,097

 

168,282

 

Supplemental disclosure of non-cash investing and financing activities

                 

Deemed dividends to preferred shareholders

 

59,428

 

15,606

 

 

 

Accrued issuance cost related to private placement

 

 

14,076

 

 

 

Accrual related to deferred initial public offering costs

 

2,127

 

 

 

 

Receivables related to exercise of stock option

 

 

(1,020

)

(3,379

)

(522

)